Browse drugs

…n 85 mg/m² every 3 weeks), lenvatinib (8 mg/day from Day 5) and Adebrelimab (1200 mg on Day 3, every 3 weeks) for 2–4 cycles. Surgery eligi…

… supplementation (30 g/day) for 8 weeks, followed by 8 weeks of MCTs (30 g/day) combined with fibre (30 g/day). The control group re…

…CSF. We gave methylprednisolone, plasma exchange, rituximab and cyclophosphamide. However, despite initial improvement, he had five relapses. We…

… that screening for type 2 diabetes using at-home self-sampling HbA1c tests, targeting individuals aged 50–75, who have not had their…

… 70s with metastatic melanoma being treated with ipilimumab and nivolumab. He presented with febrile neutropenia after lacerating a thumb…

…5% CI 1.15 to 2.27)). Among females, neither disease activity x ACPA interaction (p=0.523) nor disease activity (p=0.319) was signif…

…ed to administer short-acting anaesthetics such as propofol and remifentanil. Commonly, induction is started with a fixed effect-site concen…

…effective uterine contractions, the induction is continued with oxytocin infusion and epidural analgesia if the patient requests it. A t…

… analysis: HR of 0.85 (CI 0.72 to 1.01), p=0.070.Interpretation VKA treatment was associated with a reduction in risk of AE-COPD ho…

…d and randomised to receive either 75 mg clopidogrel or 3.75 mg prasugrel daily. Patients were stratified based on estimated glomerular f…

… (online supplemental table S10).Despite the clear advantage of LDKT, patients with diabetes were less likely to undergo LDKT, and l…

…PReCePT QI programme cost-effectively improved use of antenatal MgSO 4, with anticipated benefits to the babies who have been protecte…